LOS ANGELES, CA / ACCESSWIRE / November
26, 2018 / International Endeavors Corporation (OTC PINK:
IDVV) today announced plans to build a CBD production and
CBD products have become increasingly popular in
recent years, as it is marketed more and more as the new "it" drug
for the health and wellness set - one that has been touted as a
pain reliever and a treatment for anxiety, among other potential
applications. Last year, consumer sales of CBD products topped $350
million in the United states, more than triple the amount sold in
2014, and various estimates predict the market could reach $2
billion within the next two to four years.
The term "CBD" is a nickname for cannabidiol,
which is one of several cannabinoids, or chemical compounds, that
are found in cannabis and hemp plants. The most popular cannabinoid
is tetrahydrocannabinol, or THC, which is the main psychoactive
component in marijuana, the part that gets you high. Because CBD is
not psychoactive, it does not create the same buzzy effects
typically associated with marijuana when ingested.
What does it do?
CBD is already commonly used to relieve some
symptoms of anxiety, including insomnia, and there have been some
studies that show it to be effective in those cases. Other studies
have shown that CBD could have anti-inflammatory properties, and
many CBD products are marketed for relieving chronic pain, such as
arthritis. Multiple studies have claimed CBD to be an effective
treatment for seizures, and there are various CBD products that are
used by patients with epilepsy.
How do you use it?
CBD is typically packaged in the form of
concentrated oil or cream.
For trendy wellness products, the oil is mixed or
infused in any number of other goods, including pills, vaporizers,
beauty creams, shampoos and edibles like candy, mints and flavored
For medicinal purposes, creams and balms to treat
pain are rubbed directly on the skin and CBD oils can be taken
orally, often with a dropper that deposits a drop or two in your
Is it safe?
In December 2017, the World Health Organization
declared in a report that "cannabidiol does not appear to have
abuse potential or cause harm." The WHO also noted that CBD could
have "therapeutic value" for epileptic seizures, but that further
study is warranted to determine CBD's potential medical use.
In June 2018, the FDA approved GW
Pharmaceutical's Epidiolex, a CBD-based drug for treating epileptic
seizures - marking the first time the agency has ever approved a
drug derived from marijuana.
Recently International Endeavors Corporation
(IDVV) announced it was entering the CBD marketplace. As part of
entering the marketplace IDVV has announced plans to build a
production and distribution facility in California where its OGGL
containers can be utilized. The Company has already located several
potential locations and plans to officially break ground sometime
in early to mid 2019.
Company Spokesman Barry Smith stated ''We are
aggressively going after the CBD Marketplace. Our plan is to launch
our CBD brand very shortly with an extensive marketing campaign so
that as regulations ease in the United States we are one of the
main players. We will be updating our shareholders with more
About the OGGL: The OGGL is the
first purpose-built, self-contained, off-grid growing laboratory.
Built in a low-cost shipping container, the OGGL has integrated
solar modules and lithium-phosphate batteries coupled with a
generator backup to supply uninterrupted power to the grow room.
The OGGL is configurable for the three stages of the growing
process, which are: vegetative, flowering, and cloning.
About International Endeavors Corporation
(OTC stock symbol: IDVV)
International Endeavors Corporation focuses on
building intellectual property and making equipment sales in the
medical marijuana and legal cannabis industry through the creation
of off-grid grow labs, biomedical devices, clean-energy solutions,
and patented devices. The company is also engaged in locating and
acquiring established companies, brands, and technologies. The
companyâs real estate portfolio includes commercial property,
agricultural land, and buildings.
Forward-Looking Statements are included within
the meaning of Section 27A of the Securities Act of 1933, and
Section 21E of the Securities Exchange Act of 1934, as amended. All
statements regarding our expected future financial position,
results of operations, cash flows, financing plans, business
strategy, products and services, competitive positions, growth
opportunities, plans and objectives of management for future
operations, including words such as "anticipate," "if," "believe,"
"plan," "estimate," "expect," "intend," "may," "could," "should,"
"will," and other similar expressions are forward-looking
statements and involve risks, uncertainties and contingencies, many
of which are beyond our control, which may cause actual results,
performance, or achievements to differ materially from anticipated
results, performance, or achievements. International Endeavors
Corporation (IDVV) is under no obligation to (and expressly
disclaim any such obligation to) update or alter our
forward-looking statements, whether as a result of new information,
future events, or otherwise.
Nate Engel, CEO
Email: [email protected]
SOURCE: International Endeavors